Hebei Changshan Biochem Pharma (300255) — Financial Flexibility Index
Hebei Changshan Biochem Pharma (300255) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-6.39 Million (operating CF CN¥-30.86 Million minus capex CN¥24.47 Million) represents 0% of total liabilities (CN¥3.18 Billion). Check 300255 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hebei Changshan Biochem Pharma Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hebei Changshan Biochem Pharma across 17 annual periods. For the full cash flow conversion analysis, see Hebei Changshan Biochem Pharma cash flow conversion.
Annual Financial Flexibility Index for Hebei Changshan Biochem Pharma (2008–2024)
Year-by-year free cash flow to debt coverage for Hebei Changshan Biochem Pharma. Explore how well can Hebei Changshan Biochem Pharma service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | CN¥295.81 Million | CN¥56.22 Million | CN¥2.99 Billion | ▲ +1.4% |
| 2023 | 0.10x | CN¥273.05 Million | CN¥33.73 Million | CN¥2.80 Billion | ▼ -33.0% |
| 2022 | 0.15x | CN¥434.35 Million | CN¥3.13 Million | CN¥2.98 Billion | ▼ -0.8% |
| 2021 | 0.15x | CN¥310.95 Million | CN¥2.87 Million | CN¥2.12 Billion | ▲ +1458.4% |
| 2020 | 0.01x | CN¥16.20 Million | CN¥-183.58 Million | CN¥1.72 Billion | ▼ -89.1% |
| 2019 | 0.09x | CN¥105.28 Million | CN¥-58.13 Million | CN¥1.22 Billion | ▼ -78.4% |
| 2018 | 0.40x | CN¥527.65 Million | CN¥292.81 Million | CN¥1.32 Billion | ▲ +36.3% |
| 2017 | 0.29x | CN¥320.58 Million | CN¥162.28 Million | CN¥1.09 Billion | ▼ -8.1% |
| 2016 | 0.32x | CN¥268.48 Million | CN¥171.96 Million | CN¥842.59 Million | ▲ +411.0% |
| 2015 | 0.06x | CN¥47.20 Million | CN¥-38.14 Million | CN¥757.07 Million | ▼ -41.8% |
| 2014 | 0.11x | CN¥66.24 Million | CN¥-84.97 Million | CN¥617.87 Million | ▼ -84.7% |
| 2013 | 0.70x | CN¥251.96 Million | CN¥-15.24 Million | CN¥359.78 Million | ▲ +274.5% |
| 2012 | 0.19x | CN¥54.75 Million | CN¥-70.62 Million | CN¥292.77 Million | ▼ -21.7% |
| 2011 | 0.24x | CN¥47.47 Million | CN¥17.04 Million | CN¥198.78 Million | ▼ -24.5% |
| 2010 | 0.32x | CN¥66.80 Million | CN¥29.25 Million | CN¥211.25 Million | ▼ -29.8% |
| 2009 | 0.45x | CN¥48.26 Million | CN¥24.21 Million | CN¥107.15 Million | ▲ +259.9% |
| 2008 | -0.28x | CN¥-29.05 Million | CN¥-30.83 Million | CN¥103.16 Million | — |